Outlook Therapeutics, Inc.
For the period ended Aug 23, 2026. Filed Aug 27, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 23, 2026 · Filed Aug 27, 2026
Use the contents to explore the available documents and sections.
OTLK$0.44-0.6%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
**Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 23, 2026
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.